Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Den norske Eterfabrikk

Den norske Eterfabrikk
1900 FOUNDED
M&A STATUS
Buyout/LBO LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Operator of a pharmaceutical company. The company is engaged in developing and marketing of prescription drugs, OTC, cosmetics and chemicals. Its products include Methadone (substitution), STOP24 (sweat treatment), Malation (lice treatment), plaster remover, wart funds and ether.

Website
Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Drug Discovery
Acquirer
Primary Office
  • PO Box 10 Bøler
  • 0620 Oslo
  • Norway

Den norske Eterfabrikk Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Den norske Eterfabrikk‘s full profile, request access.

Request full access to PitchBook

Den norske Eterfabrikk Executive Team (1)

Name Title Board
Seat
Contact
Info
Kim Wedum Managing Director